Zélia Gouveia

Title: Zélia Gouveia: Innovator in Cancer Therapies

Introduction

Zélia Gouveia is a prominent inventor based in Orly, France. He has made significant contributions to the field of cancer therapies through his innovative research and development of single domain antibodies. His work is recognized for its potential impact on cancer treatment.

Latest Patents

Zélia Gouveia holds a patent for "Single Domain Antibodies and Their Use in Cancer Therapies." This patent represents a crucial advancement in the development of targeted therapies for cancer patients. He has successfully secured 1 patent in this area, showcasing his commitment to improving medical treatments.

Career Highlights

Gouveia is affiliated with the University of Zurich, where he continues to engage in groundbreaking research. His academic background and professional experience have positioned him as a leader in the field of biomedical innovation. His work has garnered attention for its potential to revolutionize cancer therapies.

Collaborations

Throughout his career, Zélia Gouveia has collaborated with notable colleagues, including Sandrine Moutel and Franck Perez. These partnerships have enhanced his research efforts and contributed to the advancement of cancer treatment methodologies.

Conclusion

Zélia Gouveia's contributions to the field of cancer therapies through his innovative patents and collaborations highlight his role as a key figure in medical research. His work continues to inspire advancements in the treatment of cancer, making a significant impact on patient care.